Neumora Therapeutics (NMRA) Income Statement (2022 - 2026)
Income Statement report data from Mar 31, 2022 to Mar 31, 2026 for Neumora Therapeutics (NMRA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | -3.84M | 3.84M | - | - | -1.41M | 1.41M | - | - |
Operating Expenses | |||||||||||||||||
Research And Development | 39M (-13.59%) | 45M (+10.24%) | 41M (+4.65%) | 39M (-25.75%) | 52M (+13.59%) | 46M (-24.28%) | 61M (+24.68%) | 49M (+6.27%) | 46M (+17.76%) | 39M (-6.59%) | 42M (+26.95%) | 33M (+11.12%) | 29M (-57.38%) | 69M (+206.87%) | 23M | - | - |
Selling General And Administrative | 14M (+3.33%) | 14M (+13.38%) | 12M (-20.50%) | 15M (-18.47%) | 19M (+10.46%) | 17M (+6.18%) | 16M (+5.46%) | 15M (+6.08%) | 14M (+27.40%) | 11M (-26.34%) | 15M (+64.26%) | 9.29M (-4.03%) | 9.68M (-58.04%) | 23M (+186.58%) | 8.05M | - | - |
Operating Expenses | 53M (-9.61%) | 58M (+1.35%) | 58M (+6.77%) | 54M (-23.82%) | 71M (+12.75%) | 63M (-17.91%) | 77M (+20.10%) | 64M (+6.24%) | 60M (-47.31%) | 114M (+100.49%) | 57M (+35.19%) | 42M (+7.38%) | 39M (-62.79%) | 105M (+244.02%) | 31M | - | - |
Depreciation And Amortization | 10K (-80.00%) | 50K | - | - | 160K (-65.96%) | 470K | - | - | 160K (-68.63%) | 510K | - | - | 160K (-72.88%) | 590K | - | - | - |
Operating Income | |||||||||||||||||
Operating Income | -52.86M (-9.61%) | -58.48M (+1.35%) | -57.70M (+6.77%) | -54.04M (-23.82%) | -70.94M (+12.75%) | -62.92M (-17.91%) | -76.65M (+20.10%) | -63.82M (+6.24%) | -60.07M (-47.31%) | -114.00M (+100.49%) | -56.86M (+35.19%) | -42.06M (+7.38%) | -39.17M (-62.79%) | -105.27M (+244.02%) | -30.60M | - | - |
Ebit | -52.86M (-9.61%) | -58.48M (+1.35%) | -57.70M (+6.77%) | -54.04M (-23.82%) | -70.94M (+12.75%) | -62.92M (-17.91%) | -76.65M (+20.10%) | -63.82M (+6.24%) | -60.07M (-47.31%) | -114.00M (+100.49%) | -56.86M (+35.19%) | -42.06M (+7.38%) | -39.17M (+22.98%) | -31.85M (+4.08%) | -30.60M (+0.76%) | -30.37M (-29.44%) | -43.04M |
EBITDA | -52.86M (-13.98%) | -61.45M (+9.71%) | -56.01M (+6.26%) | -52.71M (-25.53%) | -70.78M (-1.49%) | -71.85M (-0.88%) | -72.49M (+23.77%) | -58.57M (-2.25%) | -59.92M (-50.42%) | -120.85M (+127.89%) | -53.03M (+37.60%) | -38.54M (-1.20%) | -39.01M (+19.96%) | -32.52M (+10.84%) | -29.34M (-3.39%) | -30.37M (-29.44%) | -43.04M |
Other Income / Expenses | |||||||||||||||||
Interest Income | 1.23M (-65.74%) | 3.59M (+112.43%) | 1.69M | - | 3.07M (-80.47%) | 16M (+273.40%) | 4.21M | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 1.44M (+14.29%) | 1.26M (+68.00%) | 750K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | -200.00K | 1.58M (-6.51%) | 1.69M | - | 3.07M (-80.47%) | 16M (+273.40%) | 4.21M | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | 60K | -770.00K | 10K | -480.00K (+2300.00%) | -20.00K (-75.00%) | -80.00K (+33.33%) | -60.00K (+200.00%) | -20.00K (+100.00%) | -10.00K (-94.12%) | -170.00K | - | -40.00K (+33.33%) | -30.00K | 410K | -150.00K | - | - |
Net Income | |||||||||||||||||
Income Before Tax | -53.43M (-10.13%) | -59.45M (+4.76%) | -56.75M (+7.66%) | -52.71M (-22.36%) | -67.89M (+15.42%) | -58.82M (-18.86%) | -72.49M (+23.77%) | -58.57M (+9.03%) | -53.72M (-62.72%) | -144.09M (+171.71%) | -53.03M (+37.60%) | -38.54M | - | -130.90M | - | - | - |
Income Tax Expense | 30K | - | - | 30K (-72.73%) | 110K | - | 50K (-61.54%) | 130K | - | 270K | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -53.46M (-10.08%) | -59.45M (+4.76%) | -56.75M (+7.62%) | -52.73M (-22.44%) | -67.99M (+15.59%) | -58.82M (-18.92%) | -72.55M (+23.59%) | -58.70M (+9.27%) | -53.72M (-50.59%) | -108.73M (+105.03%) | -53.03M (+37.60%) | -38.54M (+8.20%) | -35.62M (+26.54%) | -28.15M (-4.06%) | -29.34M (-3.39%) | -30.37M (-29.44%) | -43.04M |
Net Income | -53.46M (-10.08%) | -59.45M (+4.76%) | -56.75M (+7.62%) | -52.73M (-22.44%) | -67.99M (+15.59%) | -58.82M (-18.92%) | -72.55M (+23.59%) | -58.70M (+9.27%) | -53.72M (-50.59%) | -108.73M (+105.03%) | -53.03M (+37.60%) | -38.54M (+8.20%) | -35.62M (+26.54%) | -28.15M (-4.06%) | -29.34M (-3.39%) | -30.37M (-29.44%) | -43.04M |
Comprehensive Income Net Of Tax | -53.46M (-77.44%) | -236.99M (+317.75%) | -56.73M (+7.57%) | -52.74M (-22.51%) | -68.06M (-72.07%) | -243.65M (+237.23%) | -72.25M (+23.00%) | -58.74M (+9.20%) | -53.79M (-77.13%) | -235.23M (+344.75%) | -52.89M (+36.70%) | -38.69M (+10.07%) | -35.15M (-73.31%) | -131.68M (+344.41%) | -29.63M | - | - |